We are live on
!
Find out more
Parallel Advisors Portfolio holdings
AUM
$6.56B
Turnover
11.49%
1-Year Est. Return
32.24%
This Fund
S&P 500
This Quarter
Est. Return
+4.9%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.41%
10 Year Est. Return
–
AUM
$3.9B
AUM Growth
+$213M
(+5.8%)
Cap. Flow
+$73M
Cap. Flow
% of AUM
1.87%
Top 10 Holdings %
Top 10 Hldgs %
36.05%
Holding
3,497
New
199
Increased
1,347
Reduced
1,062
Closed
172
Avg Time Held Equity + Options
4.3
years
Top 10 Avg Time Held Equity + Options
2
years
Top 20 Avg Time Held Equity + Options
3.2
years
Avg Time Held Equity only
4.3
years
Top 10 Avg Time Held Equity only
2
years
Top 20 Avg Time Held Equity only
3.2
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Core S&P 500 ETF
IVV
|
+$79.4M |
| 2 |
BlackRock US Equity Factor Rotation ETF
DYNF
|
+$52M |
| 3 |
Apple
AAPL
|
+$6.85M |
| 4 |
Vanguard Morningstar Growth ETF
VUG
|
+$6.48M |
| 5 |
Fidelity Total Bond ETF
FBND
|
+$5.87M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares MSCI USA Quality Factor ETF
QUAL
|
+$52.1M |
| 2 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$44M |
| 3 |
Invesco S&P 500 Equal Weight ETF
RSP
|
+$9.53M |
| 4 |
NVIDIA
NVDA
|
+$4.49M |
| 5 |
iShares MSCI Emerging Markets ex China ETF
EMXC
|
+$3.73M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 48.08% |
| 2 | Technology | 16.58% |
| 3 | Healthcare | 8.56% |
| 4 | Financials | 6.53% |
| 5 | Communication Services | 5.05% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2976
State Street SPDR Bloomberg Short Term High Yield Bond ETF
SJNK
$4.38B
| $874 | ﹤0.01% |
35
| – | – |
2019 Q3
19 quarters
|
|
2977
Intellia Therapeutics
NTLA
$1.59B
| $873 | ﹤0.01% |
39
-36
| -48% | -$857 |
2020 Q4
14 quarters
|
|
2978
Enova International
ENVA
$4.42B
| $872 | ﹤0.01% |
14
| – | – |
2022 Q2
8 quarters
|
|
2979
One Liberty Properties
OLP
$485M
| $869 | ﹤0.01% |
37
| – | – |
2022 Q4
6 quarters
|
|
2980
Atlanta Braves Holdings Series A
BATRA
$3.51B
| $868 | ﹤0.01% |
21
| – | – |
2020 Q2
16 quarters
|
|
2981
SSR Mining
SSRM
$6.47B
| $852 | ﹤0.01% |
189
-359
| -66% | -$1.84K |
2023 Q2
4 quarters
|
|
2982
Bel Fuse Inc Class B
BELFB
$3.16B
| $848 | ﹤0.01% |
+13
| New | +$817 |
2024 Q2
0 quarters
|
|
2983
First Bancorp
FBNC
$2.5B
| $847 | ﹤0.01% |
27
+1
| +4% | +$32 |
2020 Q2
16 quarters
|
|
2984
Gran Tierra Energy
GTE
$375M
| $841 | ﹤0.01% |
+87
| New | +$776 |
2024 Q2
0 quarters
|
|
2985
Kulicke & Soffa
KLIC
$4.35B
| $836 | ﹤0.01% |
17
+2
| +13% | +$94 |
2021 Q2
12 quarters
|
|
2986
Kalaris Therapeutics
KLRS
$52.1M
| $828 | ﹤0.01% |
50
| – | – |
2022 Q1
9 quarters
|
|
2987
Garrett Motion
GTX
$4.56B
| $825 | ﹤0.01% |
96
| – | – |
2021 Q3
11 quarters
|
|
2988
Installed Building Products
IBP
$5B
| $823 | ﹤0.01% |
4
-7
| -64% | -$1.58K |
2024 Q1
1 quarter
|
|
2989
Ryerson Holding Corp
RYZ
$1.39B
| $819 | ﹤0.01% |
42
+33
| +367% | +$850 |
2022 Q1
9 quarters
|
|
2990
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
| $816 | ﹤0.01% |
+19
| New | +$807 |
2024 Q2
0 quarters
|
|
2991
Celldex Therapeutics
CLDX
$2.27B
| $814 | ﹤0.01% |
22
| – | – |
2022 Q2
8 quarters
|
|
2992
ProShares Online Retail ETF
ONLN
$60.3M
| $813 | ﹤0.01% |
+20
| New | +$799 |
2024 Q2
0 quarters
|
|
2993
Compass Pathways
CMPS
$1.61B
| $809 | ﹤0.01% |
134
| – | – |
2021 Q4
10 quarters
|
|
2994
Covenant Logistics
CVLG
$782M
| $789 | ﹤0.01% |
32
+10
| +45% | +$232 |
2022 Q3
7 quarters
|
|
2995
DELISTED
iTeos Therapeutics
ITOS
| $787 | ﹤0.01% |
53
+42
| +382% | +$602 |
2023 Q4
2 quarters
|
|
2996
DELISTED
ModivCare
MODV
| $787 | ﹤0.01% |
30
-34
| -53% | -$860 |
2020 Q4
14 quarters
|
|
2997
United Natural Foods
UNFI
$2.91B
| $786 | ﹤0.01% |
+60
| New | +$674 |
2024 Q2
0 quarters
|
|
2998
National Vision
EYE
$1.4B
| $785 | ﹤0.01% |
60
+41
| +216% | +$671 |
2023 Q2
4 quarters
|
|
2999
ARKO Corp
ARKO
$461M
| $784 | ﹤0.01% |
+125
| New | +$672 |
2024 Q2
0 quarters
|
|
3000
TG Therapeutics
TGTX
$8.57B
| $783 | ﹤0.01% |
+44
| New | +$702 |
2024 Q2
0 quarters
|
|
Similar funds
Parallel Advisors's Q2 2024 Portfolio in Review
As of Q2 2024, Parallel Advisors held 3,497 positions worth $3.9B, up 5.8% from $3.69B the previous quarter. Its ten largest holdings account for 36% of the portfolio.
Parallel Advisors's Q2 2024 filing shows 199 new, 1,347 increased, 1,062 reduced and 172 closed positions. Its largest new stake was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M. The largest sale was iShares MSCI USA Quality Factor ETF, an estimated $52.1M.
By sector, the portfolio is most concentrated in Miscellaneous at 48% of assets, down from 49% a quarter earlier, followed by Technology and Healthcare.
- Parallel Advisors's largest Q2 2024 buy was BlackRock Flexible Income ETF: 24,596 shares worth $1.28M.
- Parallel Advisors added most to iShares Core S&P 500 ETF in Q2 2024, an estimated $79.4M increase.
- Parallel Advisors's biggest Q2 2024 reduction was iShares MSCI USA Quality Factor ETF, cutting an estimated $52.1M.
- Parallel Advisors fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $974K.
- Parallel Advisors's ten largest holdings make up 36% of its $3.9B portfolio in Q2 2024.
- Parallel Advisors opened 199 new positions and closed 172 in Q2 2024.
- Parallel Advisors's portfolio value rose 5.8% quarter-over-quarter to $3.9B.
Based on Parallel Advisors's 13F filing for Q2 2024, filed 8 Aug 2024.